170 related articles for article (PubMed ID: 11090101)
1. Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Cruz SL; Balster RL; Woodward JJ
Br J Pharmacol; 2000 Dec; 131(7):1303-8. PubMed ID: 11090101
[TBL] [Abstract][Full Text] [Related]
2. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Cruz SL; Mirshahi T; Thomas B; Balster RL; Woodward JJ
J Pharmacol Exp Ther; 1998 Jul; 286(1):334-40. PubMed ID: 9655877
[TBL] [Abstract][Full Text] [Related]
3. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
4. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
5. The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.
de Carvalho LP; Bochet P; Rossier J
Neurochem Int; 1996 Apr; 28(4):445-52. PubMed ID: 8740453
[TBL] [Abstract][Full Text] [Related]
6. Subunit-dependent inhibition of recombinant rodent N-methyl-D-aspartate receptors by a HIV-1 glycoprotein 120 derived peptide.
Wittekindt B; Betz H; Laube B
Neurosci Lett; 2000 Feb; 280(2):151-4. PubMed ID: 10686400
[TBL] [Abstract][Full Text] [Related]
7. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
Mirshahi T; Woodward JJ
Neuropharmacology; 1995 Mar; 34(3):347-55. PubMed ID: 7630488
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
[TBL] [Abstract][Full Text] [Related]
9. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
10. Effects of 2-phenoxyethanol on N-methyl-D-aspartate (NMDA) receptor-mediated ion currents.
Musshoff U; Madeja M; Binding N; Witting U; Speckmann EJ
Arch Toxicol; 1999 Feb; 73(1):55-9. PubMed ID: 10207615
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
12. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
13. Intracellular calcium enhances the ethanol sensitivity of NMDA receptors through an interaction with the C0 domain of the NR1 subunit.
Mirshahi T; Anders DL; Ronald KM; Woodward JJ
J Neurochem; 1998 Sep; 71(3):1095-107. PubMed ID: 9721734
[TBL] [Abstract][Full Text] [Related]
14. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
Williams K
Neurosci Lett; 1996 Aug; 215(1):9-12. PubMed ID: 8880741
[TBL] [Abstract][Full Text] [Related]
15. Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
Hess SD; Daggett LP; Crona J; Deal C; Lu CC; Urrutia A; Chavez-Noriega L; Ellis SB; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1996 Aug; 278(2):808-16. PubMed ID: 8768735
[TBL] [Abstract][Full Text] [Related]
16. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
[TBL] [Abstract][Full Text] [Related]
17. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
Rammes G; Mahal B; Putzke J; Parsons C; Spielmanns P; Pestel E; Spanagel R; Zieglgänsberger W; Schadrack J
Neuropharmacology; 2001 May; 40(6):749-60. PubMed ID: 11369029
[TBL] [Abstract][Full Text] [Related]
18. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
19. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects.
Callahan RJ; Au JD; Paul M; Liu C; Yost CS
Anesth Analg; 2004 Mar; 98(3):653-9, table of contents. PubMed ID: 14980914
[TBL] [Abstract][Full Text] [Related]
20. Polyamines potentiate responses of N-methyl-D-aspartate receptors expressed in xenopus oocytes.
McGurk JF; Bennett MV; Zukin RS
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9971-4. PubMed ID: 1702227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
